Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III,randomized clinical trial |
| |
摘 要: |
|
收稿时间: | 3 November 2022 |
本文献已被 ScienceDirect 等数据库收录! |
|